Sélection de la langue

Gouvernement du Canada / Government of Canada

Recherche

N-propionylated group B meningococcal polysaccharide glycoconjugate vaccine against group B meningococcal meningitis

Par Conseil national de recherches du Canada

DOITrouver le DOI : https://doi.org/10.1016/S1201-9712(97)90080-1
AuteurRechercher : 1
Affiliation
  1. Conseil national de recherches du Canada. Institut des sciences biologiques du CNRC
FormatTexte, Article
ConférenceJenner Symposium of the 7th International Congress for Infectious Diseases, June 10, 1996, Hong, Kong
Sujetconformational epitopes; glycoconjugate vaccine; group B Neisseria meningitidis; meningococcal vaccines; molecular mimicry; N-propionylated group B meningococcal polysaccharide
Résumé
Although group B Neisseria meningitidis is responsible for a significant amount of meningococcal meningitis, its capsular polysaccharide is precluded from the current vaccine because of its poor immunogenicity. This phenomenon is attributable to structural mimicry between the group B meningococcal polysaccharide (GBMP) and human tissue antigens. One simple way to avoid this problem is to use as a vaccine a synthetic N-propionylated (NPr) form of the GBMP, which when conjugated to tetanus toxoid (IT, induces, in mice, high titers of bactericidal antibodies against all group B meningococci. Fortuitously, the major population of NPr GBMP-specific antibodies, even though not cross-reactive with the GBMP, contains all the protective activity. Only a minor population of GBMP cross-reactive antibodies are produced, but even the level of these antibodies can be significantly reduced by adjuvant manipulation. Thus the NPr GBMP mimics a highly conserved capsule-associated epitope that could be the basis of a potential vaccine against group B meningitis. To further define this protective epitope, a series of GBMP-specific monoclonal antibodies of the IgG isotype were produced using an (NeuPr)≈₃₅−TT conjugate vaccine. Unlike GBMP-specific antibodies, which recognize epitopes found only on the extended helical form, some of those secreted by the NPr GBMP-specific clones were also able to recognize short (random coil) segments of the NPr GBMP However, only those antibodies specific for the extended helical epitopes were protective as defined by bactericidal assays or passive protection experiments.
Date de publication
Maison d’éditionElsevier
International Society for Infectious Diseases
Dans
  • International Journal of Infectious Diseases 1, nº 3 (1997) : 158–164.
Langueanglais
Publications évaluées par des pairsOui
Numéro du CNRCJENNINGS1997
Numéro NPARC9362349
Exporter la noticeExporter en format RIS
Signaler une correctionSignaler une correction (s'ouvre dans un nouvel onglet)
Identificateur de l’enregistrement516896c1-c0c0-4344-a989-a7a311b046fd
Enregistrement créé2009-07-10
Enregistrement modifié2022-07-11
Date de modification :